Glaxosmithkline Brasil Ltda is a finished-dose manufacturer based in Brazil. It appears in 593 regulatory filings across 6 regulators, without an active US DMF or CEP on file. Its filings concentrate with ANVISA (Brazil), INHRR (VE) and ARCSA (EC). Its GMP standing is certified by ANVISA (Brazil).
| Site | FDA FEI |
|---|---|
| RIO DE JANEIRO, Brazil | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| ANVISA (Brazil) | 555 | 2 |
| INHRR (VE) | 19 | None |
| ARCSA (EC) | 8 | None |
| ISP (CL) | 6 | None |
| MINSA (CR) | 4 | None |
| EEC_EAEU | 1 | None |
Choose your molecules and target markets. Glaxosmithkline Brasil Ltda comes back tiered against every other supplier able to file there.
Start for free